Rezolute Inc (RZLT)
5.55
+0.13
(+2.40%)
USD |
NASDAQ |
Nov 05, 10:23
Rezolute Price to Book Value: 2.540 for Nov. 5, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
November 04, 2024 | 2.480 |
November 01, 2024 | 2.517 |
October 31, 2024 | 2.508 |
October 30, 2024 | 2.489 |
October 29, 2024 | 2.599 |
October 28, 2024 | 2.576 |
October 25, 2024 | 2.645 |
October 24, 2024 | 2.535 |
October 23, 2024 | 2.453 |
October 22, 2024 | 2.421 |
October 21, 2024 | 2.238 |
October 18, 2024 | 2.219 |
October 17, 2024 | 2.169 |
October 16, 2024 | 2.265 |
October 15, 2024 | 2.206 |
October 14, 2024 | 2.187 |
October 11, 2024 | 2.151 |
October 10, 2024 | 2.137 |
October 09, 2024 | 2.151 |
October 08, 2024 | 2.187 |
October 07, 2024 | 2.187 |
October 04, 2024 | 2.256 |
October 03, 2024 | 2.242 |
October 02, 2024 | 2.155 |
October 01, 2024 | 2.100 |
Date | Value |
---|---|
September 30, 2024 | 2.219 |
September 27, 2024 | 2.279 |
September 26, 2024 | 2.233 |
September 25, 2024 | 2.265 |
September 24, 2024 | 2.146 |
September 23, 2024 | 2.192 |
September 20, 2024 | 2.325 |
September 19, 2024 | 2.206 |
September 18, 2024 | 2.228 |
September 17, 2024 | 2.283 |
September 16, 2024 | 2.357 |
September 13, 2024 | 2.402 |
September 12, 2024 | 2.388 |
September 11, 2024 | 2.352 |
September 10, 2024 | 2.379 |
September 09, 2024 | 2.429 |
September 06, 2024 | 1.990 |
September 05, 2024 | 1.999 |
September 04, 2024 | 2.150 |
September 03, 2024 | 2.150 |
August 30, 2024 | 2.178 |
August 29, 2024 | 2.173 |
August 28, 2024 | 2.136 |
August 27, 2024 | 2.191 |
August 26, 2024 | 2.150 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.2824
Minimum
Nov 29 2023
45.84
Maximum
Oct 14 2020
4.043
Average
1.859
Median
Apr 20 2021
Price to Book Value Benchmarks
Actinium Pharmaceuticals Inc | 1.269 |
Moderna Inc | 1.748 |
NovaBay Pharmaceuticals Inc | -- |
Palatin Technologies Inc | -- |
iBio Inc | 1.096 |
Price to Book Value Related Metrics
Price | 5.55 |
Earnings Yield | -23.96% |
Market Cap | 307.30M |